Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer

Genetics and Molecular Research - Brazil
doi 10.4238/2015.march.20.20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Genetics and Molecular Research

Related search

Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy® System in Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

The HER2 Phenotype of Circulating Tumor Cells in HER2-positive Early Breast Cancer: A Translational Research Project of a Prospective Randomized Phase III Trial

PLoS ONE
Multidisciplinary
2017English

Mesenchymal and Stemness Circulating Tumor Cells in Early Breast Cancer Diagnosis

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Optimal Treatment of Early Stage HER2-positive Breast Cancer

Cancer
Cancer ResearchOncology
2018English

Correlation of HER2 Status Between Primary Tumors and Corresponding Circulating Tumor Cells in Advanced Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

The Impact of HER2 Phenotype of Circulating Tumor Cells in Metastatic Breast Cancer: A Retrospective Study in 107 Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Circulating Tumor Cells in Patients With Breast Cancer Dormancy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Circulating Tumor Cells Detection in Tumor Draining Vein of Breast Cancer Patients

Scientific Reports
Multidisciplinary
2019English

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy